ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine is a paper indexed in ScholarIQ from OpenAlex.
How many citations does ARISE: A Phase 3 randomized trial of erenumab for episodic migraine have?
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine has 594 citations in the OpenAlex counts ScholarIQ stores.
When was ARISE: A Phase 3 randomized trial of erenumab for episodic migraine published?
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine has 2018 year in the ScholarIQ index.
What is the open-access status of ARISE: A Phase 3 randomized trial of erenumab for episodic migraine?
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine has closed oa status in the ScholarIQ index.
What is the DOI of ARISE: A Phase 3 randomized trial of erenumab for episodic migraine?
The DOI for ARISE: A Phase 3 randomized trial of erenumab for episodic migraine is on the source record.
What is the PMID of ARISE: A Phase 3 randomized trial of erenumab for episodic migraine?
The PMID for ARISE: A Phase 3 randomized trial of erenumab for episodic migraine is on the source record.
What is the OpenAlex record for ARISE: A Phase 3 randomized trial of erenumab for episodic migraine?
The OpenAlex for ARISE: A Phase 3 randomized trial of erenumab for episodic migraine is on the source record.